Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03708055 · ClinicalTrials.gov registry record · NA

Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors

A NA study of Overweight and Anatomic Stage II Breast Cancer AJCC v8, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT03708055: Completed NA study of Overweight and Anatomic Stage II Breast Cancer AJCC v8, sponsored by University of Arizona.

NCT03708055 is a NA study of Overweight and Anatomic Stage II Breast Cancer AJCC v8 that has completed, run by University of Arizona. The registered enrollment target is 27 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03708055, a NA study of Overweight and Anatomic Stage II Breast Cancer AJCC v8, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well weight bearing exercise works in preventing frailty in stage I-IIIA breast cancer survivors. Weight bearing exercise, including muscle-strengthening, aerobic, flexibility, and balance exercises, can decrease fat and increase muscle, which may lead to reduced frailty.

Primary Outcome

Demonstrate reproducibility of forearm muscle activation and subcutaneous fat measures in a healthy convenience sample/population (N= 10). Standard anthropometric measurements (height, weight, waist, hip and arm circumferences) will be taken at baseline and 8weeks. A total body dual energy X-ray absorptiometry (DXA) scan, with an effective radiation dose of about 0.01 mSv, which is about the same as background radiation in one day according to the American College of Radiology (http://www.radiol

Interventions

  • BEHAVIORAL Exercise Intervention

Study Locations (1)

Arizona

  • The University of Arizona Medical Center-University Campus - Tucson

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2008-07-24
Est. Completion 2017-04-04
Phase NA
University of Arizona

349 total trials

What the finished NCT03708055 record still lists

NCT03708055 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower).

The record links to 10 conditions, with Overweight appearing as the primary indexed condition, and to 1 intervention - of which Exercise Intervention is the first listed.

NCT03708055 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT03708055 about?

NCT03708055 is a clinical study titled "Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors". This trial studies how well weight bearing exercise works in preventing frailty in stage I-IIIA breast cancer survivors. Weight bearing exercise, including muscle-strengthening, aerobic, flexibility, and balance exercises, can decrease fat and increase muscle, which may lead to reduced frailty.

What is the current status of trial NCT03708055?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2008-07-24. Estimated completion is 2017-04-04.

What conditions does trial NCT03708055 study?

This clinical trial studies the following conditions: Overweight, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8.

What interventions are being tested in trial NCT03708055?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03708055?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03708055 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03708055's enrollment target sits among peer trials

27 172nd of 197 higher than 25 of 197 other Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03708055, the US trial registry maintained by the National Library of Medicine. NCT03708055 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.